|
|
|
Insider
Information: |
Deerfield Special Situations Fund International Lt |
Relationship: |
Possible Members of 10... |
City: |
Road Town, Tortola |
State: |
D8 |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
12 |
|
Direct
Shares |
130,000 |
|
Indirect Shares
|
19,698,472 |
|
|
Direct
Value |
$330,500 |
|
|
Indirect Value
|
$141,754,594 |
|
|
Total
Shares |
19,828,472 |
|
|
Total
Value |
$142,085,094 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
21
|
4
|
Stock
price went up :
|
0
|
3
|
Stock
price went down : |
21
|
1
|
|
|
|
Gain/Loss Ratio : |
-21.0
|
3.0
|
Percentage
Gain/Loss : |
-30.4%
|
-70.7%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Dynavax Technologies Corp |
DVAX |
Possible members of 10... |
2006-03-03 |
0 |
2006-10-04 |
2,035,137 |
Premium* |
|
ISTA Pharmaceuticals Inc |
ISTA |
Possible members of 10... |
2006-06-01 |
80,000 |
2006-06-01 |
2,791,863 |
Premium* |
|
Par Pharmaceutical Companies Inc |
PRX |
10% Owner |
2007-02-01 |
15,000 |
2007-02-01 |
2,173,177 |
Premium* |
|
Corautus Genetics Inc |
VEGF |
Possible Member of 10%... |
|
0 |
2007-11-06 |
1,244,708 |
Premium* |
|
Cyclacel Pharmaceuticals Inc |
CYCC |
10% Owner |
|
0 |
2008-11-19 |
881,743 |
Premium* |
|
Neurogesx Inc |
NGSX |
10% Owner |
|
0 |
2009-07-13 |
987,880 |
Premium* |
|
Anadys Pharmaceuticals Inc |
ANDS |
10% Owner |
2008-10-18 |
0 |
2008-10-18 |
904,903 |
Premium* |
|
Neurometrix Inc |
NURO |
Possible Members of 10... |
|
0 |
2010-12-14 |
781,833 |
Premium* |
|
Nxstage Medical, Inc. |
NXTM |
10% Owner |
2009-12-15 |
10,000 |
2009-12-15 |
3,694,836 |
Premium* |
|
Talon Therapeutics Inc |
TLON |
Possible Members of 10... |
|
0 |
2012-07-05 |
136,849 |
Premium* |
|
Fibrocell Science Inc |
FCSC |
Possible Members of 10... |
2010-08-16 |
0 |
2010-08-16 |
1,162,800 |
Premium* |
|
Rigel Pharmaceuticals Inc |
RIGL |
Possible Members of 10... |
2010-11-03 |
25,000 |
2010-11-03 |
2,902,743 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
148 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
NURO |
Neurometrix Inc |
Possible Members of 10% Group |
|
2010-09-27 |
4 |
S |
$0.58 |
$116 |
I/I |
(200) |
1,638,041 |
0 |
- |
|
NURO |
Neurometrix Inc |
Possible Members of 10% Group |
|
2010-10-26 |
4 |
S |
$0.59 |
$58,410 |
I/I |
(99,000) |
1,574,478 |
0 |
- |
|
RIGL |
Rigel Pharmaceuticals Inc |
10% Owner |
|
2010-11-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
6,075,000 |
|
- |
|
RIGL |
Rigel Pharmaceuticals Inc |
Possible Members of 10% Group |
|
2010-11-03 |
4 |
S |
$7.55 |
$58,218 |
I/I |
(7,711) |
2,902,743 |
0 |
- |
|
NURO |
Neurometrix Inc |
Possible Members of 10% Group |
|
2010-11-16 |
4 |
S |
$0.58 |
$35,895 |
I/I |
(61,882) |
1,534,745 |
0 |
- |
|
NURO |
Neurometrix Inc |
Possible Members of 10% Group |
|
2010-11-17 |
4 |
S |
$0.53 |
$120,937 |
I/I |
(216,839) |
1,395,522 |
0 |
- |
|
NURO |
Neurometrix Inc |
Possible Members of 10% Group |
|
2010-11-18 |
4 |
S |
$0.56 |
$368,163 |
I/I |
(623,926) |
994,930 |
0 |
- |
|
NURO |
Neurometrix Inc |
Possible Members of 10% Group |
|
2010-12-14 |
4 |
S |
$0.50 |
$169,130 |
I/I |
(331,900) |
781,833 |
0 |
- |
|
TLON |
Talon Therapeutics Inc |
Possible Members of 10% Group |
|
2011-05-17 |
4 |
S |
$1.12 |
$189,081 |
I/I |
(168,822) |
1,796,586 |
0 |
- |
|
TLON |
Talon Therapeutics Inc |
Possible Members of 10% Group |
|
2011-05-18 |
4 |
S |
$1.11 |
$85,202 |
I/I |
(76,759) |
1,762,525 |
0 |
- |
|
TLON |
Talon Therapeutics Inc |
Possible Members of 10% Group |
|
2011-05-19 |
4 |
S |
$1.11 |
$57,763 |
I/I |
(52,039) |
1,739,433 |
0 |
- |
|
TLON |
Talon Therapeutics Inc |
Possible Members of 10% Group |
|
2011-05-20 |
4 |
S |
$0.99 |
$75,905 |
I/I |
(76,395) |
1,705,533 |
0 |
- |
|
TLON |
Talon Therapeutics Inc |
Possible Members of 10% Group |
|
2011-05-23 |
4 |
S |
$1.00 |
$16,207 |
I/I |
(16,207) |
1,698,341 |
0 |
- |
|
TLON |
Talon Therapeutics Inc |
Possible Members of 10% Group |
|
2011-05-24 |
4 |
S |
$1.00 |
$281,001 |
I/I |
(281,001) |
1,573,653 |
0 |
- |
|
TLON |
Talon Therapeutics Inc |
Possible Members of 10% Group |
|
2011-05-26 |
4 |
S |
$1.01 |
$123,099 |
I/I |
(121,880) |
1,519,570 |
0 |
- |
|
TLON |
Talon Therapeutics Inc |
Possible Members of 10% Group |
|
2011-05-27 |
4 |
S |
$0.99 |
$44,253 |
I/I |
(44,700) |
1,499,734 |
0 |
- |
|
TLON |
Talon Therapeutics Inc |
Possible Members of 10% Group |
|
2011-05-31 |
4 |
S |
$0.99 |
$26,029 |
I/I |
(26,292) |
1,488,067 |
0 |
- |
|
TLON |
Talon Therapeutics Inc |
Possible Members of 10% Group |
|
2011-06-03 |
4 |
S |
$1.01 |
$9,221 |
I/I |
(9,130) |
1,484,015 |
0 |
- |
|
TLON |
Talon Therapeutics Inc |
Possible Members of 10% Group |
|
2011-06-06 |
4 |
S |
$1.02 |
$43,860 |
I/I |
(43,000) |
1,464,934 |
0 |
- |
|
TLON |
Talon Therapeutics Inc |
Possible Members of 10% Group |
|
2011-06-07 |
4 |
S |
$1.03 |
$56,650 |
I/I |
(55,000) |
1,440,536 |
0 |
- |
|
TLON |
Talon Therapeutics Inc |
Possible Members of 10% Group |
|
2011-06-13 |
4 |
S |
$1.02 |
$33,845 |
I/I |
(33,181) |
1,425,812 |
0 |
- |
|
TLON |
Talon Therapeutics Inc |
Possible Members of 10% Group |
|
2011-06-23 |
4 |
AS |
$0.94 |
$142,212 |
I/I |
(141,207) |
644,013 |
0 |
- |
|
TLON |
Talon Therapeutics Inc |
Possible Members of 10% Group |
|
2011-06-24 |
4 |
AS |
$1.07 |
$95,009 |
I/I |
(88,793) |
1,328,885 |
0 |
- |
|
TLON |
Talon Therapeutics Inc |
Possible Members of 10% Group |
|
2011-06-27 |
4 |
AS |
$1.06 |
$16,430 |
I/I |
(15,500) |
1,322,354 |
0 |
- |
|
TLON |
Talon Therapeutics Inc |
Possible Members of 10% Group |
|
2011-07-14 |
4 |
AS |
$0.99 |
$13,068 |
I/I |
(13,200) |
1,316,791 |
0 |
- |
|
148 Records found
|
|
Page 5 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|